335 related articles for article (PubMed ID: 4639018)
1. The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue.
Tallman JF; Johnson WG; Brady RO
J Clin Invest; 1972 Sep; 51(9):2339-45. PubMed ID: 4639018
[TBL] [Abstract][Full Text] [Related]
2. The catabolism of Tay-Sachs ganglioside in rat brain lysosomes.
Tallman JF; Brady RO
J Biol Chem; 1972 Dec; 247(23):7570-5. PubMed ID: 4636324
[No Abstract] [Full Text] [Related]
3. The preparation of Tay-Sachs ganglioside specifically labeled in either the N-acetylneuraminosyl or N-acetylgalactosaminyl portion of the molecule.
Tallman JF; Kolodny EH; Brady RO
Methods Enzymol; 1975; 35():541-8. PubMed ID: 1121293
[No Abstract] [Full Text] [Related]
4. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
Poulos A; Holding J; Carey WF
Clin Chim Acta; 1982 Apr; 120(3):331-40. PubMed ID: 6210469
[TBL] [Abstract][Full Text] [Related]
5. Hydrolysis of Tay-Sachs ganglioside by beta-hexosaminidase A of human liver and urine.
Li YT; Mazzotta MY; Wan CC; Orth R; Li SC
J Biol Chem; 1973 Nov; 248(21):7512-5. PubMed ID: 4745777
[No Abstract] [Full Text] [Related]
6. Preparation of radioactive Tay-Sachs ganglioside labeled in the sialic acid moiety.
Kolodny EH; Brady RO; Quirk JM; Kanfer JN
J Lipid Res; 1970 Mar; 11(2):144-9. PubMed ID: 5418476
[TBL] [Abstract][Full Text] [Related]
7. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of an alteration of ganglioside metabolism in Tay-Sachs disease.
Kolodny EH; Brady RO; Volk BW
Biochem Biophys Res Commun; 1969 Oct; 37(3):526-31. PubMed ID: 5388728
[No Abstract] [Full Text] [Related]
9. Tay-sachs disease. Demonstration of the stored ganglioside in cultured cells from brain biopsy.
Batzdorf U; Sarlieve LL; Gold VA; Menkes JH
Arch Neurol; 1969 Jun; 20(6):650-2. PubMed ID: 4890200
[No Abstract] [Full Text] [Related]
10. Enzyme alterations and lipid storage in three variants of Tay-Sachs disease.
Sandhoff K; Harzer K; Wässle W; Jatzkewitz H
J Neurochem; 1971 Dec; 18(12):2469-89. PubMed ID: 5135907
[No Abstract] [Full Text] [Related]
11. Gangliosidosis with total hexosaminidase deficiency: clinical, biochemical and ultrastructural studies and comparison with conventional cases of Tay-Sachs disease.
Fontaine G; Résibois A; Tondeur M; Jonniaux G; Farriaux JP; Voet W; Maillard E; Loeb H
Acta Neuropathol; 1973 Jan; 23(2):118-32. PubMed ID: 4349527
[No Abstract] [Full Text] [Related]
12. Tay-sachs disease.
Brady RO
N Engl J Med; 1969 Nov; 281(22):1243-4. PubMed ID: 5347842
[No Abstract] [Full Text] [Related]
13. Absence of hexosaminidase A and B in a normal adult.
Dreyfus JC; Poenaru L; Svennerholm L
N Engl J Med; 1975 Jan; 292(2):61-3. PubMed ID: 1109441
[TBL] [Abstract][Full Text] [Related]
14. Tay-Sachs disease and normal cerebellar cells in culture: elevated levels of lysosomal enzymes in Tay-Sachs disease cells.
Hoffman LM; Brooks SE; Schneck L
J Neurosci Res; 1982; 8(1):49-55. PubMed ID: 6816949
[TBL] [Abstract][Full Text] [Related]
15. [On a component of the mixture of brain gangliosides, which is transferred to the Tay-Sachs ganglioside under the influence of neuraminidase].
Klenk E; Naoi M
Hoppe Seylers Z Physiol Chem; 1968 Mar; 349(3):288-92. PubMed ID: 4302220
[No Abstract] [Full Text] [Related]
16. Subcellular fractions from Tay-Sachs brains: ganglioside, lipid, and protein composition and hexosaminidase activities.
Kornguth S; Wannamaker B; Kolodny E; Geison R; Scott G; O'Brien JF
J Neurol Sci; 1974 Jul; 22(3):383-406. PubMed ID: 4857837
[No Abstract] [Full Text] [Related]
17. Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage.
Seyrantepe V; Canuel M; Carpentier S; Landry K; Durand S; Liang F; Zeng J; Caqueret A; Gravel RA; Marchesini S; Zwingmann C; Michaud J; Morales CR; Levade T; Pshezhetsky AV
Hum Mol Genet; 2008 Jun; 17(11):1556-68. PubMed ID: 18270209
[TBL] [Abstract][Full Text] [Related]
18. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
Hechtman P; Boulay B; Bayleran J; Andermann E
Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
[TBL] [Abstract][Full Text] [Related]
19. The Tay-Sachs disease fibroblast model: failure to respond to exogenous hexosaminidase A.
Schneck L; Amsterdam D; Brooks SE; Rosenthal AL; Volk BW
Pediatrics; 1973 Aug; 52(2):221-6. PubMed ID: 4721444
[No Abstract] [Full Text] [Related]
20. Asialo GM-ganglioside in brain fetal Tay-Sachs disease.
Schneck L; Pinkett B; Volk BW
J Neurochem; 1975 Jan; 24(1):183-4. PubMed ID: 1110360
[No Abstract] [Full Text] [Related]
[Next] [New Search]
